Cerus
CERS
#7346
Rank
A$0.64 B
Marketcap
A$3.34
Share price
0.00%
Change (1 day)
29.21%
Change (1 year)

Earnings for Cerus (CERS)

Earnings in 2025 (TTM): -A$11.51 Million

According to Cerus's latest financial reports the company's current earnings are A$0.19 Billion. In 2024 the company made an earning of -A$16.69 Million, an increase over its 2023 earnings that were of -A$40.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus from 1997 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$11.51 Million-31.05%
2024 -A$16.69 Million-58.95%
2023 -A$40.65 Million-20.74%
2022 -A$51.29 Million-25.7%
2021 -A$69.03 Million-11.99%
2020 -A$78.43 Million-14%
2019 -A$91.2 Million21.73%
2018 -A$74.92 Million-0.65%
2017 -A$75.41 Million-10.96%
2016 -A$84.69 Million4.24%
2015 -A$81.25 Million50.99%
2014 -A$53.81 Million-10.08%
2013 -A$59.85 Million184.13%
2012 -A$21.07 Million-7.91%
2011 -A$22.88 Million
2009 -A$32.3 Million-24.69%
2008 -A$42.89 Million-25.2%
2007 -A$57.34 Million330.54%
2006 -A$13.32 Million1.49%
2005 -A$13.13 Million-61.02%
2004 -A$33.67 Million
2002 -A$83.28 Million10.02%
2001 -A$75.69 Million34.25%
2000 -A$56.38 Million61.02%
1999 -A$35.02 Million-18.81%
1998 -A$43.13 Million93.08%
1997 -A$22.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$4.59 B-45,284.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$20.53 M-301.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.34 B-3,453.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.34 Million 31.12%๐Ÿ‡บ๐Ÿ‡ธ USA